Chen-Kan TSENG MD

Authority in Pediatric Oncology Treatment

Radiotherapy for adult CNS tumor, esophageal cancer, sarcoma, and the pediatric cancers, radiosurgery

Profile

After residency training completed on Jul. 1997 here in Chang Gung Memorial hospital, I stayed as a physician in Department of radiation oncology, and focused my patient care on adult CNS tumor, esophageal cancer, sarcoma, and the pediatric cancers. I worked as the team leader of our esophageal cancer team from 2009-2016. Except being the member of Taiwan’s radiation oncology society, I worked as the Secretary General in this society from 2014-2016. As to the other professional organizations, I am the member of ASTRO (American society of therapeutic radiation oncology) since 1998, SNO (society of neuro-oncology) since 2007 and PROS (Pediatric radiation oncology society) since 2011.

Specialty

Radiotherapy for adult CNS tumor, esophageal cancer, sarcoma, and the pediatric cancers, radiosurgery.

Success Cases

I treated about 100 new cases of esophageal cancer yearly since year 2000, and also 50 adult CNS tumors, 30 soft tissue sarcomas, 20 pediatric cancer patients yearly. As a part of team work in oncology treatment, it is not fair to give all credits to radiotherapy in the success rate of every kinds of cancer, but our treatment results are comparable to the most modern series.

Education

MD, Taipei medical college (1985-1992)

PhD, Clinical Medical Sciences, Chang Gung University (2005- )


Experiences

2011/09~2011/12    Proton Therapy Center, Mass. General Hospital, US

1992~1993　Trainee, Department of Medicine, Shin Kong Hospital, Taiwan

1993~1997　Resident, Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Taiwan

1997~1999, 2000~　Attending, Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital, Taiwan

1999~2000　Director, Department of Radiation Oncology, Luodong Bo-Ai Hospital


Current Appointment

Attending, Department of Radiation Oncology, Chang Gung Memorial Hospital, Taiwan


Affiliations

Secretary General, Taiwan Radiation Oncology Society (2014-2016)

Childhood Cancer Foundation

Medical Consultant, Childhood Brain Tumor Association

Member, American Society for Radiation Oncology (ASTRO)

Member, Society for Neuro-Oncology (SNO)

Member, Paediatric Radiation Oncology Society (PROS)

 

Major Publications

  1. Tseng, C. K., Tsang N.M. Tsai J. S., Wei G. J., Jiang T. H., Pai P.C., Chang J.T.C. (2003) Radiotherapy to primary cns germinoma: how large an irradiated volume is justified for tumor control?  J Neuro-Oncol 62, 343-348. (SCI)
  2. Tseng CK, Tsang NM, Jaing TH, Liau CT, Wu CT, Lin KL. (2011) Outcome of central nervous system germinoma treatment by chemoradiation. J Pediatr Hematol Oncol. 33(4):e138-42.
  3. Jaing T. H., Wang H. S., Hung I. J., Tseng C. K., Yang C. P., Hung P. C., Lui T. N. (2002) Intracranial Germ Cell Tumors: A Retrospective Study of Forty-four Children. Pediatr Neurol 26, 369-373. (SCI)
  4. Jaing, T. H., Yang, C. P., Hung, I. J., Wang, H. S., Tseng, C. K., Hsueh, C. (2003) Brain metastases in children with neuroblastoma--a single-institution experience. Medical & Pediatric Oncology 2003, 41 (6), 570-1. (SCI)
  5. Jaing, T. H., Wang, H. S., Tsay, P. K., Tseng, C. K., Jung, S. M., Lin, K. L., Lui, T. N. (2004) Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.  Journal of Neuro-Oncology 2004, 68(3), 255-61. (SCI)
  6. Jaing, T. H., Wang, H. S., Tseng, C. K., Hsueh, C., Wang, C. J., Tsai, Y. J. (2004) Simultaneous development of bilateral retrobulbar and intradural spinal masses following donor lymphocyte infusions for acute lymphoblastic leukemia relapsing after bone marrow transplantation. Journal of Pediatric Hematology/Oncology 2004, 26(7), 447-50. (SCI)
  7. Huang YC, Tseng CK, Chang CN, Wei KC, Liao CC, Hsu PW. LINAC radiosurgery for intracranial cavernous malformation: 10-year experience, Clin Neurol Neurosurg. 2006 Dec; 108 (8):750-6. (SCI)
  8. Hsu PW, Chang CN, Tseng CK, Wei KC, Wang CC, Chuang CC, Huang YC. (2007) Treatment of epileptogenic cavernomas: surgery versus radiosurgery. Cerebrovasc Dis. 2007;24(1):116-20. (SCI)
  9. Jaing TH, Lin KL, Tsay PK, Hsueh C, Hung PC, Wu CT, Tseng CK. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases. J Pediatr Hematol Oncol. 2008
  10. Hsieh, P. C., Wu, C. T., Lin, K. L., Jaing, T. H., Tseng, C. K., Lui, T. N., Jung SM. (2008). The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis. Childs Nerv Syst, 24(12), 1463-1467. (SCI)
  11. Jaing, T. H., Tsay, P. K., Yang, C. P., Hung, I. J., Wen, Y. C., & Tseng, C. K. (2008). Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience. Transplant Proc, 40(10), 3643-3645. (SCI)
  12. Hsu, P. W., Chang, C. N., Lee, S. T., Huang, Y. C., Chen, H. C., Wang, C. C., Hsu YH, Tseng CK, Chen YL, Wei KC (2010). Outcomes of 75 patients over 12 years treated for acoustic neuromas with linear accelerator-based radiosurgery. J Clin Neurosci, 17(5), 556-560. (SCI)
  13. Wei, K. C., Huang, C. Y., Chen, P. Y., Feng, L. Y., Wu, T. W., Chen, S. M., Tsai HC, Lu YJ, Tsang NM, Tseng CK, Pai PC, Shin JW. (2010). Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res, 30(1), 253-259. (SCI)
  14. Jaing TH, Wu CT, Chen SH, Hung PC, Lin KL, Jung SM, Tseng CK. (2011) Intracranial tumors in infants: a single institution experience of 22 patients. Childs Nerv Syst. 2011 Mar;27(3):415-9. (SCI)
  15. Tseng CK, Tsang NM, Jaing TH, Liau CT, Wu CT, Lin KL. (2011) Outcome of central nervous system germinoma treatment by chemoradiation. J Pediatr Hematol Oncol. 33(4):e138-42. (SCI)
  16. Jaing, T.H., et al., Rescue by hematopoietic progenitor cells derived from engrafted cord blood unit in a child with brain tumor after transplantation for T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol, 201

Short term result of proton therapy to relapsed hepatoblastoma in the abdomen. A 4 year-old girl, who was noted to have elevated alfa-fetoprotein after chemotherapy and radical excision of hepatic tumor, recurrent node in the peripancreatic area was found, PET/CT revealed no other lesion, and proton therapy 50CGE/ 25fx was used to treat the relapsed node, no acute complication was observed during treatment, and the alfa-fetoprotein level dropped steadily to within normal limits after the treatment and remained stable 1 year after the treatment.

(the dose profile of proton therapy in axial ad sagittal view)

(the serial follow up of alfa-fetoprotein level, black box indicated the duration on proton therapy, the red line indicates the cut-off point of normal vs. abnormal)